The public will have a chance to see what until now has been, mostly, understood only by managed care insiders: how a prescription drug winds up on a formulary.
Express Scripts, one of the largest pharmacy benefit managers, will soon begin to post conclusions of its pharmacy and therapeutics committee on its web site.
Express Scripts wants to give the public and health care professionals an idea of the thought process and logic involved when the P&T committee considers whether to add a drug to the formulary.
The PBM will not post minutes of P&T meetings, but will summarize discussions about products, whether and under what circumstances they should be covered, and at what out-of-pocket cost to the member.
PBMs are just now beginning to gain public attention. Reports about how PBMs control the pharmacy benefit gained coverage in the mainstream press last year, triggering some public resentment.
View the discussion thread.
Our other journal
P&T Journal for November 2014
LETTER TO THE EDITOR
Medications for Parkinson’s Disease
The Changing Roles of P&T Committees
Epilepsy Management: Newer Agents, Unmet Needs, and Future Treatment Strategies
Modest Growth Seen in Epilepsy Market
European Society of Cardiology and Transcatheter Cardiovascular Therapeutics
“Generic: The Unbranding of Modern Medicine,” by Jeremy A. Greene, MD, PhD
Misadministration of IV Insulin Associated With Dose Measurement And Hyperkalemia Treatment
FDA’s Proposed 503B Draft Compounding Guidance Raises Concerns of All Kinds
New Drugs/Drug News
Pharmaceutical Approval Update
Riociguat (Adempas): a Novel Agent For the Treatment of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension